π Ebola Outbreak in Congo Sees Merck Vaccine and Gilead Drug Use
The Ebola outbreak in the Democratic Republic of Congo is worsening, prompting a shift in the response strategy. Health officials are now deploying the Merck vaccine alongside the Gilead drug in affected areas. The outbreak has seen a significant rise in cases reported throughout the past few weeks. This escalation requires enhanced medical intervention to control the spread of the virus. Authorities are intensifying monitoring efforts to manage the ongoing public health crisis. π